Review: The potential role of bevacizumab in early stages and locally advanced non-small cell lung cancer

Review: The potential role of bevacizumab in early stages and locally advanced non-small cell lung cancer

Improving outcomes for early-stage non-small cell lung cancer (NSCLC) is a major research area considering that a significant percentage of such patients develop recurrent disease within 5 years of complete lung resection. Adjuvant chemotherapy prolongs survival, with an absolute improvement in 5-ye...

Full description

Bibliographic Details
Main Authors: Clorinda Schettino, Maria Anna Bareschino, Antonio Rossi, Paolo Maione, Vincenzo Castaldo, Nicole Mazzeo, Paola Claudia Sacco, Marianna Luciana Ferrara, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Format: Article
Language:English
Published: SAGE Publishing 2009-07-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758834009338635

Internet

https://doi.org/10.1177/1758834009338635

Similar Items